AstraZeneca's lung cancer drug fast-tracked for first-line treatment 1 234 567

AstraZeneca's lung cancer drug fast-tracked for first-line treatment

livecharts.co.uk

The US drug regulator has given AstraZeneca's osimertinib treatment for patients with advanced metastatic non-small cell lung cancer 'breakthrough therapy designation' to fast-track its becoming a first-line treatment.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567